UTD-20029-37436
1 vaccination
2 coded responses
14 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 140 / NY
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-07
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-08
Registered in v-safe
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-09
- 2021-03-10
-
2021-03-11
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-03-13
- 2021-03-16
- 2021-03-21
- 2021-03-28
- 2021-04-04
- 2021-04-13
- 2021-04-18
- 2021-06-06
-
2021-09-05
Survey response — 6 months, dose 1MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-03-07
Survey response — 12 months, dose 1MedDRA: Delivery, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Pregnancy and live birth. Pre-eclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-03-07
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-03-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-07 | Janssen/Johnson & Johnson |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-07 | Unsuccessful |
Free text
Release 9 — 6 months, dose 1
Symptoms: Pregnancy
Release 11 — 12 months, dose 1
Symptoms: Pregnancy and live birth. Pre-eclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | · | · | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release